Cardiovascular Research · 2019 · 78 citations · 61 references
Herein, we used a combination of in vivo and in vitro methods to systematically screen CML TKIs for cardiotoxicity, identify novel molecular mechanisms for TKI cardiotoxicity, and identify less cardiotoxic alternatives.
61
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2015 · 11.9K citations · Full text
Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
Neil P. Shah, Chris Tran, Francis Y. Lee et al. · Science · 2004 · 1.8K citations
Imatinib Resistance, Imatinib-resistant Bcr-abl Mutants, Chronic Myeloid Leukemia +14